University · founded 1911
Anderson University - South Carolina
Anderson, United States · andersonuniversity.edu
- Citations, last 5 years
- 1 240
- Works, last 5 years
- 169
- h-index
- 34
- Scientists listed
- 11
- Grants since 2016
- 1 743
Grants received
2019–2024 · research · R01
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
Jingfei Ma · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
Jingfei Ma · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
Mitchell J. Frederick · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Dihua Yu · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
How age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm
Francesca Cole · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · fellowship · F31
Diffusion-Weighted Imaging-Based Adaptive Replanning for the MR-Linac
Brigid Anne Mcdonald · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Elucidating and targeting subtype-specific driver in pancreatic cancer
Haoqiang Ying · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Regulation of RNA polymerase II pausing and directionality by ATP-dependent chromatin remodelers
Blaine Bartholomew · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
Michael Davies · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
Mitchell J. Frederick · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · fellowship · F32
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer-Child Care Supplement
Joy Marie Mcdaniel · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
Jonathan M Kurie · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R50
Molecular Mechanisms of Chemotherapy-Induced Cognitive Dysfunction
Khalid S Mohammad · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Elucidating and targeting subtype-specific driver in pancreatic cancer
Haoqiang Ying · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management
Elizabeth Gardner Grubbs · Anderson University - South Carolina · funded by U.S. Food and Drug Administration
2019–2022 · research · R33
Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma
Joya Chandra · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · research · R01
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
Roza Insafetdinovna Nurieva · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · career development · K01
Identifying Risk Factors for Antibiotic Resistance via Integration of Epidemiology and Metagenomics
Jessica Rhea Galloway-Pena · Anderson University - South Carolina · funded by National Institutes of Health
2019 · contract · N01
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019 - 1/24/2024)
(Contact) · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R33
Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma
Joya Chandra · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
Jonathan M Kurie · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
Adoptive T Cell Therapy for Pancreatic Cancer
Cassian Yee · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
Marina Y Konopleva · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
Michael Davies · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Strategies for Persistent Agitated Delirium in Palliative Care
David Hui · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · research · R00
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer
Di Zhao · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing heterochromatin dysfunction as a driving alteration in cancer
Jason Huse · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
A Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma
Vinay K Puduvalli · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Adoptive T Cell Therapy for Pancreatic Cancer
Cassian Yee · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
Goldy C George · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Powel H Brown · Anderson University - South Carolina · funded by National Institutes of Health
2019–2020 · research · R61
Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma
Joya Chandra · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
Goldy C George · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Elucidating and targeting subtype-specific driver in pancreatic cancer
Haoqiang Ying · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53
Wenyi Wang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain
Sadhan Majumder · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
Roza Insafetdinovna Nurieva · Anderson University - South Carolina · funded by National Institutes of Health